Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin (Q42988889)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 June 2009
edit
Language Label Description Also known as
English
Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin
scientific article published on 22 June 2009

    Statements

    Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin (English)
    N Hiramatsu
    T Yakushijin
    K Mochizuki
    K Imanaka
    A Kaneko
    M Oshita
    H Hagiwara
    T Nagase
    T Hijioka
    K Katayama
    S Tamura
    H Yoshihara
    Y Yoshida
    T Tatsumi
    K Ohkawa
    T Kanto
    A Kasahara
    T Takehara
    N Hayashi
    22 June 2009
    586-594

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit